MORhomes announces £13.2m loan to Soho

MORhomes PLC
17 December 2024
 


MORhomes PLC

17 December 2024

 

NOT FOR DISTRIBUTION TO ANY U.S. PERSON OR TO ANY PERSON OR ADDRESS IN THE U.S.

MORhomes PLC

Publication of Pricing Supplement in relation to the issue of £12,500,000 3.40 per cent. Secured Notes due 2038/2040 (to be consolidated and form a single series with the existing £440,100,000 3.40 per cent. Notes due 2038/2040 issued on 19 February 2019, 31 October 2019, 19 November 2019, 15 April 2020, 2 October, 26 October 2020, 26 January 2021, 26 March 2021, 8 November 2021 and 16 August 2022) (the "Notes") under the £5,000,000,000 Secured Euro Medium Term Note Programme (the "Programme")

MORhomes PLC (the "Issuer") has today published a pricing supplement dated 17 December 2024 containing details of the Notes (the "Pricing Supplement"). To view the Pricing Supplement, please paste the following URL into the address bar of your browser:

http://www.rns-pdf.londonstockexchange.com/rns/4566Q_1-2024-12-17.pdf

MORhomes PLC has also issued a press release, which is available at the following URL:

http://www.rns-pdf.londonstockexchange.com/rns/4566Q_2-2024-12-17.pdf

For further information please contact:

Andrew Morton

MORhomes PLC, Future Business Centre, Kings Hedges Road, Cambridge CB4 2HY

07498 581246

 

DISCLAIMER ‑ INTENDED ADDRESSEES

Please note that the information contained in the Pricing Supplement may be addressed to and/or targeted at persons who are residents of particular countries (specified or referred to in the Programme Memorandum dated 11 January 2024 (the "Programme Memorandum") of the Issuer in connection with the Programme only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Programme Memorandum is not addressed. Prior to relying on the information contained in the Programme Memorandum and/or the Pricing Supplement you must ascertain from the Programme Memorandum whether or not you are part of the intended addressees of the information contained therein.

Your right to access the Pricing Supplement is conditional upon complying with the above requirement.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings